150 related articles for article (PubMed ID: 21714686)
1. Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial.
Lazarevic B; Boezelijn G; Diep LM; Kvernrod K; Ogren O; Ramberg H; Moen A; Wessel N; Berg RE; Egge-Jacobsen W; Hammarstrom C; Svindland A; Kucuk O; Saatcioglu F; Taskèn KA; Karlsen SJ
Nutr Cancer; 2011; 63(6):889-98. PubMed ID: 21714686
[TBL] [Abstract][Full Text] [Related]
2. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
deVere White RW; Hackman RM; Soares SE; Beckett LA; Li Y; Sun B
Urology; 2004 Feb; 63(2):259-63. PubMed ID: 14972467
[TBL] [Abstract][Full Text] [Related]
3. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.
Dalais FS; Meliala A; Wattanapenpaiboon N; Frydenberg M; Suter DA; Thomson WK; Wahlqvist ML
Urology; 2004 Sep; 64(3):510-5. PubMed ID: 15351581
[TBL] [Abstract][Full Text] [Related]
4. The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy.
Lazarevic B; Hammarström C; Yang J; Ramberg H; Diep LM; Karlsen SJ; Kucuk O; Saatcioglu F; Taskèn KA; Svindland A
Br J Nutr; 2012 Dec; 108(12):2138-47. PubMed ID: 22397815
[TBL] [Abstract][Full Text] [Related]
5. Lycopene and soy isoflavones in the treatment of prostate cancer.
Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones.
Jarred RA; Keikha M; Dowling C; McPherson SJ; Clare AM; Husband AJ; Pedersen JS; Frydenberg M; Risbridger GP
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1689-96. PubMed ID: 12496063
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of exisulind for treatment of recurrent prostate cancer after radical prostatectomy.
Goluboff ET; Prager D; Rukstalis D; Giantonio B; Madorsky M; Barken I; Weinstein IB; Partin AW; Olsson CA;
J Urol; 2001 Sep; 166(3):882-6. PubMed ID: 11490238
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
[TBL] [Abstract][Full Text] [Related]
9. Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.
deVere White RW; Tsodikov A; Stapp EC; Soares SE; Fujii H; Hackman RM
Nutr Cancer; 2010; 62(8):1036-43. PubMed ID: 21058191
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement.
Schröder FH; Roobol MJ; Boevé ER; de Mutsert R; Zuijdgeest-van Leeuwen SD; Kersten I; Wildhagen MF; van Helvoort A
Eur Urol; 2005 Dec; 48(6):922-30; discussion 930-1. PubMed ID: 16263208
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
[TBL] [Abstract][Full Text] [Related]
12. Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation.
Rannikko A; Petas A; Rannikko S; Adlercreutz H
Prostate; 2006 Jan; 66(1):82-7. PubMed ID: 16114063
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones in the treatment of prostate cancer.
Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
[TBL] [Abstract][Full Text] [Related]
14. Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.
Hamilton-Reeves JM; Banerjee S; Banerjee SK; Holzbeierlein JM; Thrasher JB; Kambhampati S; Keighley J; Van Veldhuizen P
PLoS One; 2013; 8(7):e68331. PubMed ID: 23874588
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.
Bass R; Perry B; Langenstroer P; Thrasher JB; Dennis KL; Tawfik O; Holzbeierlein J
J Urol; 2009 Feb; 181(2):615-9; discussion 619-20. PubMed ID: 19091346
[TBL] [Abstract][Full Text] [Related]
16. Carob pulp preparation rich in insoluble fibre lowers total and LDL cholesterol in hypercholesterolemic patients.
Zunft HJ; Lüder W; Harde A; Haber B; Graubaum HJ; Koebnick C; Grünwald J
Eur J Nutr; 2003 Oct; 42(5):235-42. PubMed ID: 14569404
[TBL] [Abstract][Full Text] [Related]
17. High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma.
Beer TM; Lemmon D; Lowe BA; Henner WD
Cancer; 2003 Mar; 97(5):1217-24. PubMed ID: 12599228
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of pharmacologically-active antioxidant phytomedicine Radical Fruits in treatment hypercholesteremia at men.
Abidov M; Jimenez Del Rio M; Ramazanov A; Kalyuzhin O; Chkhikvishvili I
Georgian Med News; 2006 Nov; (140):78-83. PubMed ID: 17179595
[TBL] [Abstract][Full Text] [Related]
19. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
Saltissi D; Morgan C; Rigby RJ; Westhuyzen J
Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]